Test Price
2,800 AED✅ Home Collection Available
KLF1 Gene Congenital Dyserythropoietic Anaemia Type 4 (CDA IV) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل KLF1 Gene Dyserythropoietic Anaemia, Congenital, Type 4 Genetic Test في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Certified Sequencing.
- Premium Logistics: Paid Hospital‑Grade Home Collection using ISO Certified Cold‑Chain.
- Clinical Guidance: Telephonic Post‑Test Clinical Interpretation by Specialist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ملخص تنفيذي
يُعد اختبار تسلسل الجين KLF1 باستخدام تقنية الجيل التالي (NGS) أداة تشخيصية دقيقة للكشف عن طفرات جين KLF1 المسبّبة لفقر الدم الخلقي غير الطبيعي من النوع الرابع (CDA IV). يتميز بضمان دقة تشخيصية تصل إلى 99.9%، وخدمة جمع عينات منزلية معتمدة بمعايير الآيزو، وإمكانية التواصل المباشر مع مستشار وراثي بعد النتيجة.
Overview
The KLF1 Genetic Test offers definitive molecular diagnosis of Congenital Dyserythropoietic Anaemia Type 4 by interrogating the full coding region of the KLF1 gene with deep coverage. يُعتبر هذا التحليل المرجعي المعتمد لتأكيد التشخيص لدى المرضى المشتبه بإصابتهم بهذا الاضطراب الوراثي النادر.
| Feature | Our KLF1 NGS Test | Sanger Single‑Gene Sequencing |
|---|---|---|
| Detection Sensitivity | 99.9% (missense, nonsense, splice, small indels) | ≈95%, may miss mosaic variants |
| Technology | Next Generation Sequencing (30× coverage) | Capillary electrophoresis – one amplicon at a time |
| Turnaround Time | 3–4 Weeks | 5–8 Weeks (fragmented workflow) |
| Bioinformatics & Reporting | ACMG classification, full clinical report | Limited; often no copy‑number analysis |
Physician Insight & Safety Protocol
“As a clinician practicing under DHA licence 61713011, I understand the anxiety a genetic diagnosis can bring. This test provides high‑resolution evidence for precise counselling, but it must always be interpreted alongside the complete haematological phenotype. Please remember that a normal result does not exclude all forms of CDA; careful follow‑up remains essential.”
— Dr. PRABHAKAR REDDY (DHA: 61713011), Haematology & Genetics Consultant
Medication Warning
Do not discontinue any prescribed medication, including iron chelators, transfusions, or supportive therapies, without explicit instruction from your treating physician.
Safety & Exclusion Criteria
Exclusion Criteria for Home Blood Collection
- Haemodynamically unstable patient (hypotension, altered consciousness).
- Active bleeding or INR >3.0 with risk of uncontrolled haemorrhage.
- Severe thrombocytopenia (platelets < 20 × 10⁹/L).
- Patient unable to provide informed consent (guardian required for minors).
Emergency Red Flags – Seek Immediate Medical Attention
- Acute haemolytic crisis: jaundice + dark urine + sudden pallor.
- High fever (>38.5°C) with signs of infection in a known CDA patient.
- Severe abdominal pain or splenic enlargement causing breathing difficulty.
- Loss of consciousness or extreme fatigue with heart failure symptoms.
Frequently Asked Questions
Q1: How does the KLF1 NGS test differ from a standard anaemia panel?
The KLF1 test directly sequences the gene causing Congenital Dyserythropoietic Anaemia Type 4, whereas a routine anaemia panel only measures haematological indices without genetic confirmation. يتجاوز هذا الفحص الفحوص التقليدية ليكشف عن الطفرة الجينية المحددة المسؤولة عن فقر الدم الخلقي غير الطبيعي، مما يسمح بتشخيص جزيئي قاطع وتوجيه العلاج بدقة.
Q2: Is the suitable for children, and what sample type is needed?
Yes, under paediatrician consent, a simple blood draw, extracted DNA, or one blood drop on an FTA card is sufficient — making it minimally invasive for paediatric patients. نعم، بموافقة طبيب الأطفال، يكفي أخذ عينة دم بسيطة أو قطرة دم على بطاقة FTA، مما يجعل الإجراء مريحًا وآمنًا للأطفال ولا يتطلب تخديرًا.
Q3: What does a negative result mean if my child still has symptoms?
A negative KLF1 result excludes only mutations in this gene; other congenital anaemia forms (e.g., CDA type I, II, III, or other haemolytic conditions) should be investigated through comprehensive genomic panels. تعني النتيجة السلبية استبعاد طفرات جين KLF1 فقط، ولا تنفي وجود فقر دم خلقي آخر؛ لذا قد يوصي الطبيب بفحوصات جينية أوسع لتحديد السبب الدقيق للأعراض.
UAE Regulatory Compliance & Laboratory Accreditation
- Federal Decree‑Law No. 41 of 2024 (Art. 87) – All genetic testing adheres to regulated genetic counselling and data privacy mandates.
- CDS Law 2026 (Minors) – Testing of minors requires documented guardian consent and an approved genetic counselling session.
- UAE PDPL – All patient data is processed under the Personal Data Protection Law with encrypted storage and limited access.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – Ensuring consistent laboratory quality management.
Facility Licence: 9834453 | Support WhatsApp: +971 54 548 8731
2026 Medical Coding Highlights
- ICD‑10‑CM: D64.4 (Congenital dyserythropoietic anaemia), Z15.89 (Genetic susceptibility to other disease), Z13.84 (Encounter for screening for genetic disease).
- LOINC: 101606-2 – KLF1 gene [Mutations] in Blood or Tissue by Sequencing. https://loinc.org/101606-2/
- Methodology: Full‑gene NGS with 30× average coverage, variant interpretation per ACMG/AMP guidelines.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians